Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cell Therapy for Parkinson’s Disease

29.04.2004


According to research work at the University Hospital, cell therapy could improve many of the motor deficits of patients with Parkinson’s Disease.



With Parkinson’s a degeneration of cell groups takes place and so, from a conceptual perspective, the perfect treatment would be to replace the cells lost. The big drawback in the search for a suitable cell is to find one that survives for a lengthy period within the brain, that integrates well into the brain structures in order to comply with a series of functions and one that is not rejected by the organism of the patient.

At the University Hospital a line of investigation is being carried out that is based on experimenting with stem cells having the ability to transform themselves into neurones and incorporate themselves into the brain. Two types of cells are currently being tested: one type consists of adult bone marrow stem cells. The aim is to obtain dopaminergic neurones from adult bone marrow stem cells. The next step will be to test to see if these neurones are able, once implanted in the brain, to ameliorate Parkinsonian symptoms in animals.


Motor system recovery

The second source of donor cells is cell cultures from the carotid body. That research was initiated five years ago in animals which had carotid body cell aggregates implanted in the brain. The programme running tests on twelve macaco monkeys (of the Cebidae family) is now coming to an end and it has been shown that motor recovery has been maintained over a period of twelve months. These animals show a moderate improvement in Parkinsonian symptoms, and efforts have thus been centred on achieving enhanced motor performance. This is why these cells are being cultured and isolated in order to effect motor recovery on implantation into the brain. Laboratory data suggest that there exists a population of immature neural cells that grow very well in cell cultures and can serve as an efficacious source for their implantation.

The next stage will be to know if these cells cultivated in the carotid body of animals also exist in the human carotid body. If it turns out that that both cellular types have the same characteristics and there is a good response at an experimental level, the treatment can be transferred to humans.


But it should be made clear that the lines of investigation in cellular therapy are not directed at curing the disease but that, in some patients, it can be observed that clinical improvement can be superior to that achieved with other, alternative treatments. Although not attempting a cure for the ailment, it is possible to improve many of the motor deficits of the patients and even reverse the illness to more initial stages. However, until what causes the disease is known, it cannot be cured.


Contact :
Garazi Andonegi
ELHUYAR Fundazioa
garazi@elhuyar.com
(+34) 943363040

Garazi Andonegi | Basque research
Further information:
http://www.basqueresearch.com/berria_irakurri.asp?Gelaxka=1_1&Berri_Kod=458&hizk=I
http://www.unav.es/cun

More articles from Health and Medicine:

nachricht The end of pneumonia? New vaccine offers hope
23.10.2017 | University at Buffalo

nachricht Scientists track ovarian cancers to site of origin: Fallopian tubes
23.10.2017 | Johns Hopkins Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>